| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.06▼ | 4.13▼ | 4.13▼ | 4.07▼ | 3.84▲ |
| MA10 | 4.10▼ | 4.16▼ | 4.21▼ | 4.06▼ | 3.67▲ |
| MA20 | 4.12▼ | 4.26▼ | 4.21▼ | 3.95▲ | 3.77▲ |
| MA50 | 4.16▼ | 4.15▼ | 4.15▼ | 3.70▲ | 3.39▲ |
| MA100 | 4.24▼ | 4.16▼ | 4.13▼ | 3.75▲ | 11.05▼ |
| MA200 | 4.24▼ | 4.12▼ | 3.74▲ | 3.25▲ | 24.13▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | -0.030▼ | -0.029▼ | 0.007▲ | 0.118▲ |
| RSI | 26.280▼ | 36.711▼ | 41.363▼ | 52.604▲ | 51.567▲ |
| STOCH | 2.381▼ | 12.578▼ | 8.556▼ | 53.230 | 49.810 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -60.769 | -39.500 |
| CCI | -133.124▼ | -145.411▼ | -146.852▼ | 13.221 | 84.368 |
| MA | $XFOR Price Crossed Below MA(7) | Set Alert |
|
Tuesday, March 17, 2026 07:30 AM
X4 Pharmaceuticals (NASDAQ: XFOR), a company focused on improving the lives of people with rare hematology diseases, today reported financial results for the fourth quarter and year ended December 31, ...
|
|
Tuesday, March 17, 2026 04:45 AM
Global 4WARD Phase 3 Chronic Neutropenia Trial On Track to Complete Enrollment in Q3 2026 - - Positive Opinion from European Medicines Agency Recommending Marketing Authorization of Mavorixafor for ...
|
|
Monday, March 09, 2026 09:15 AM
Analyst sentiment across three small-cap biotechs has turned notably positive, with fresh coverage initiations and maintained Buy-equivalent ratings from institutional research desks ahead of 2026 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/03/26 | 4.31 | 4.35 | 4.03 | 4.04 | 320,161 |
| 26/03/26 | 4.08 | 4.51 | 3.99 | 4.31 | 653,297 |
| 25/03/26 | 3.85 | 4.16 | 3.85 | 4.09 | 397,900 |
| 24/03/26 | 4.07 | 4.07 | 3.81 | 3.82 | 283,770 |
| 23/03/26 | 4.34 | 4.3553 | 4.001 | 4.07 | 360,822 |
| 20/03/26 | 4.14 | 4.495 | 4.10 | 4.28 | 643,418 |
| 19/03/26 | 4.01 | 4.175 | 3.92 | 4.17 | 259,000 |
| 18/03/26 | 4.16 | 4.42 | 3.98 | 4.05 | 557,724 |
| 17/03/26 | 3.75 | 4.23 | 3.6291 | 4.23 | 614,008 |
| 16/03/26 | 3.64 | 3.695 | 3.53 | 3.56 | 442,049 |
|
|
||||
|
|
||||
|
|